Daniel Bergman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel Bergman has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- Elana Judith Fertig
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
20 shared publications - Atul Deshpande
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland
18 shared publications - Elizabeth M. Jaffee
Johns Hopkins Convergence Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
18 shared publications - Ashani T. Weeraratna
Johns Hopkins University
17 shared publications - Genevieve Stein-O’bRien
Johns Hopkins University
17 shared publications - Luciane Tsukamoto Kagohara
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center
17 shared publications
Latest Publications
- Open Access
UQ-PhysiCell: An extensible Python framework for uncertainty quantification and model analysis in PhysiCell
Agent-based models (ABMs) are widely used to study complex multiscale biological systems, particularly in cancer research. However, their high-dimensional parameter spaces, stochasticity, and computational costs pose significant challenges for uncertainty quantification, calibration, and systematic comparison of competing mechanistic hypotheses. PhysiCell has evolved into a growing ecosystem of open-source tools supporting physics-based multicellular modeling, including model construction, visualization, and data integration. However, despite these advances, systematic support for uncertainty-aware model analysis, scalable parameter exploration, and formal calibration workflows remains limited. Here, we introduce UQ-PhysiCell, an open-source Python package that enables uncertainty quantification, calibration, and model selection for PhysiCell models using a modular and scalable workflow. UQ-PhysiCell acts as a manager of PhysiCell simulation inputs and outputs, including parameters, initial conditions, rules, and MultiCellDS-compliant objects, and provides automated orchestration of large ensembles of simulations. The framework supports multiple levels of parallelism to accelerate the analysis, including the parallel execution of independent simulations, stochastic replicates, and downstream analysis tasks. UQ-PhysiCell integrates seamlessly with established Python libraries for sensitivity analysis, optimization, Bayesian inference, and surrogate modeling, allowing users to construct customized pipelines that match their modeling goals and computational resource requirements. By decoupling model execution from statistical analysis and emphasizing extensibility and reproducibility, UQ-PhysiCell lowers the barrier to applying rigorous uncertainty-aware methodologies to agent-based modeling and supports the systematic evaluation of PhysiCell models in biological and biomedical research. Author summary: We developed UQ-PhysiCell to address a key challenge in agent-based modeling: the systematic quantification of uncertainty in complex stochastic simulations. PhysiCell is widely used to model multicellular biological systems, particularly in cancer research; however, practical tools for uncertainty analysis, calibration, and model comparison are often developed in an ad hoc manner. This makes the results difficult to reproduce and limits the ability to rigorously evaluate competing biological hypotheses. UQ-PhysiCell provides a flexible Python framework that manages the inputs and outputs of PhysiCell simulations and enables large-scale computational analysis. We designed the software to be modular, allowing users to build their own analysis pipelines and combine different methodologies for sensitivity analysis, calibration, and model selection. Rather than enforcing a single workflow, UQ-PhysiCell supports customization to match specific scientific questions and computational requirements. To make uncertainty-aware analyses feasible for computationally intensive agent-based models, UQ-PhysiCell implements multiple parallelism strategies, enabling the concurrent execution of simulations, stochastic replicates, and downstream analyses. By promoting reproducibility, scalability, and methodological flexibility, UQ-PhysiCell helps researchers move beyond single best-fit simulations toward more reliable and interpretable computational modeling.
Open AccessUQ-PhysiCell: An extensible Python framework for uncertainty quantification and model analysis in PhysiCell
Agent-based models (ABMs) are widely used to study complex multiscale biological systems, particularly in cancer research. However, their high-dimensional parameter spaces, stochasticity, and computational costs pose significant challenges for uncertainty quantification, calibration, and systematic comparison of competing mechanistic hypotheses. PhysiCell has evolved into a growing ecosystem of open-source tools supporting physics-based multicellular modeling, including model construction, visualization, and data integration. However, despite these advances, systematic support for uncertainty-aware model analysis, scalable parameter exploration, and formal calibration workflows remains limited. Here, we introduce UQ-PhysiCell, an open-source Python package that enables uncertainty quantification, calibration, and model selection for PhysiCell models using a modular and scalable workflow. UQ-PhysiCell acts as a manager of PhysiCell simulation inputs and outputs, including parameters, initial conditions, rules, and MultiCellDS-compliant objects, and provides automated orchestration of large ensembles of simulations. The framework supports multiple levels of parallelism to accelerate the analysis, including the parallel execution of independent simulations, stochastic replicates, and downstream analysis tasks. UQ-PhysiCell integrates seamlessly with established Python libraries for sensitivity analysis, optimization, Bayesian inference, and surrogate modeling, allowing users to construct customized pipelines that match their modeling goals and computational resource requirements. By decoupling model execution from statistical analysis and emphasizing extensibility and reproducibility, UQ-PhysiCell lowers the barrier to applying rigorous uncertainty-aware methodologies to agent-based modeling and supports the systematic evaluation of PhysiCell models in biological and biomedical research. Author summary: We developed UQ-PhysiCell to address a key challenge in agent-based modeling: the systematic quantification of uncertainty in complex stochastic simulations. PhysiCell is widely used to model multicellular biological systems, particularly in cancer research; however, practical tools for uncertainty analysis, calibration, and model comparison are often developed in an ad hoc manner. This makes the results difficult to reproduce and limits the ability to rigorously evaluate competing biological hypotheses. UQ-PhysiCell provides a flexible Python framework that manages the inputs and outputs of PhysiCell simulations and enables large-scale computational analysis. We designed the software to be modular, allowing users to build their own analysis pipelines and combine different methodologies for sensitivity analysis, calibration, and model selection. Rather than enforcing a single workflow, UQ-PhysiCell supports customization to match specific scientific questions and computational requirements. To make uncertainty-aware analyses feasible for computationally intensive agent-based models, UQ-PhysiCell implements multiple parallelism strategies, enabling the concurrent execution of simulations, stochastic replicates, and downstream analyses. By promoting reproducibility, scalability, and methodological flexibility, UQ-PhysiCell helps researchers move beyond single best-fit simulations toward more reliable and interpretable computational modeling.
- Open Access
Tumor-immune trajectory context connects static tissue architecture to clinical outcomes
Multiplexed tissue imaging (MTI) has revealed recurrent tumor microenvironment (TME) architectures with prognostic value, yet these measurements are inherently static, obscuring dynamic changes in the TME that govern therapeutic response. Here, we introduce a trajectory-centric framework that reconstructs continuous TME dynamics by integrating agent-based mathematical modeling and simulation with state space analysis. This approach yields a mechanistically constrained reference landscape built entirely from in silico simulation, and onto which static patient biospecimens can be projected and mapped onto simulated TME trajectories. Systematic simulation of tumor-immune interactions in triple-negative breast cancer identifies six metastable TME states connected by transition pathways spanning immune control to immune escape. Mapping MTI data from two independent patient cohorts, including longitudinal samples from a randomized immunotherapy trial, validates this landscape by positioning individual biospecimens along inferred TME trajectories rather than in static states. We show that treatment-phase TME states, but not pre-treatment configurations, robustly predict immunotherapy response, and identical terminal states can arise from distinct trajectory histories corresponding to immune failure or resolved inflammation. Thus, this framework enables mechanistic simulations to define a reference dynamical landscape that serves as a coordinate system for interpreting static clinical spatial data, providing a principled basis for evaluating consistency, predictiveness, and clinical relevance across independent patient cohorts. Altogether, this study advances spatial tumor profiling from static state classification of human tissues to dynamic trajectory inference, establishing a quantitative framework for trajectory-informed, state-guided, and temporally adaptive immunotherapy strategies.
Open AccessTumor-immune trajectory context connects static tissue architecture to clinical outcomes
Multiplexed tissue imaging (MTI) has revealed recurrent tumor microenvironment (TME) architectures with prognostic value, yet these measurements are inherently static, obscuring dynamic changes in the TME that govern therapeutic response. Here, we introduce a trajectory-centric framework that reconstructs continuous TME dynamics by integrating agent-based mathematical modeling and simulation with state space analysis. This approach yields a mechanistically constrained reference landscape built entirely from in silico simulation, and onto which static patient biospecimens can be projected and mapped onto simulated TME trajectories. Systematic simulation of tumor-immune interactions in triple-negative breast cancer identifies six metastable TME states connected by transition pathways spanning immune control to immune escape. Mapping MTI data from two independent patient cohorts, including longitudinal samples from a randomized immunotherapy trial, validates this landscape by positioning individual biospecimens along inferred TME trajectories rather than in static states. We show that treatment-phase TME states, but not pre-treatment configurations, robustly predict immunotherapy response, and identical terminal states can arise from distinct trajectory histories corresponding to immune failure or resolved inflammation. Thus, this framework enables mechanistic simulations to define a reference dynamical landscape that serves as a coordinate system for interpreting static clinical spatial data, providing a principled basis for evaluating consistency, predictiveness, and clinical relevance across independent patient cohorts. Altogether, this study advances spatial tumor profiling from static state classification of human tissues to dynamic trajectory inference, establishing a quantitative framework for trajectory-informed, state-guided, and temporally adaptive immunotherapy strategies.
- Open Access
Enhancing Predictive Accuracy in Immunotherapy Models through Data Integration and Parameter Identifiability
Immune checkpoint inhibitors (ICIs), a class of immunotherapy, offer promising benefits but face challenges such as low response rates to be used as a broadly effective treatment for all patients. In this study, we use a set of ordinary different equation (ODE) models and bladder cancer in vivo data as a case study to outline a biologically informed, data-driven framework for formulating, calibrating and validating immunotherapy models, and thus ensuring their predictive reliability. We consider multiple treatment scenarios and distinct immune cell-mediated killing mechanisms for tumor cells of different antigenicity. By integrating sensitivity analysis and identifiability analysis with targeted experimental design, we demonstrate how mathematical models can move beyond qualitative insight to quantitative prediction. We generate virtual cohorts to show that insufficient data integration leads to systematically overestimated therapeutic benefits of ICIs. We also explore dosing schedules that enhance survival or reduce dosage without compromising survival.
Open AccessEnhancing Predictive Accuracy in Immunotherapy Models through Data Integration and Parameter Identifiability
Immune checkpoint inhibitors (ICIs), a class of immunotherapy, offer promising benefits but face challenges such as low response rates to be used as a broadly effective treatment for all patients. In this study, we use a set of ordinary different equation (ODE) models and bladder cancer in vivo data as a case study to outline a biologically informed, data-driven framework for formulating, calibrating and validating immunotherapy models, and thus ensuring their predictive reliability. We consider multiple treatment scenarios and distinct immune cell-mediated killing mechanisms for tumor cells of different antigenicity. By integrating sensitivity analysis and identifiability analysis with targeted experimental design, we demonstrate how mathematical models can move beyond qualitative insight to quantitative prediction. We generate virtual cohorts to show that insufficient data integration leads to systematically overestimated therapeutic benefits of ICIs. We also explore dosing schedules that enhance survival or reduce dosage without compromising survival.
- Open Access
From Sparse Data to Smart Decisions: Region-Specific Policy Evaluation via Simulation
Effective disease outbreak response requires actionable, region-specific guidance, but most modeling tools rely on detailed surveillance or strong assumptions, such as random mixing. Agent-based models (ABMs) allow us to capture key heterogeneity in contact patterns and intervention mechanisms, but linking these models with data is often computationally intractable, particularly at the larger scales needed for decision-making (e.g., county- or state-level). We present a simulation-based framework that combines ABMs with surrogate modeling to infer key transmission and severity parameters using only routine case and hospitalization data. This enables local health agencies to evaluate candidate interventions while explicitly accounting for uncertainty. Applied to COVID-19 in Michigan counties, our method recovers core parameters (transmissibility, latent period, asymptomatic transmissibility, underreporting, hospitalization risk, and duration) that align with empirical estimates, while demonstrating regional variation linked to age and comorbidity patterns. We find that intervention effectiveness cannot be reliably predicted from simple demographic predictors such as age structure, population density, or workforce participation. While school closures aligned with child population in some settings, other interventions showed weak or counterintuitive relationships with demographics. Traditional ODE models with random mixing assumptions cannot capture how interventions target specific contact networks, making it impossible to assess whether demographic proxies predict intervention success. Our framework addresses this gap by explicitly modeling intervention mechanisms within heterogeneous contact structures. Solely using routine case and hospitalization data, our method enables practical, uncertainty-aware decision support for local health agencies facing COVID-19, influenza, RSV, or future novel pathogens. 1 Significance Statement: During emerging outbreaks, policymakers must act before data are complete. We introduce a computational framework that bridges the gap between sparse local data and agent-based models, enabling evaluation of interventions under significant uncertainty. Our method captures how specific contact networks drive local transmission by moving beyond the random-mixing assumptions of compartmental models. We apply our framework to COVID-19 in diverse Michigan counties. Our method identifies which intervention policies are robust to the inherent uncertainty in early outbreaks for each specific community. This disease-agnostic approach empowers local agencies to make evidence-based decisions tailored to their unique population structures and contact patterns.
Open AccessFrom Sparse Data to Smart Decisions: Region-Specific Policy Evaluation via Simulation
Effective disease outbreak response requires actionable, region-specific guidance, but most modeling tools rely on detailed surveillance or strong assumptions, such as random mixing. Agent-based models (ABMs) allow us to capture key heterogeneity in contact patterns and intervention mechanisms, but linking these models with data is often computationally intractable, particularly at the larger scales needed for decision-making (e.g., county- or state-level). We present a simulation-based framework that combines ABMs with surrogate modeling to infer key transmission and severity parameters using only routine case and hospitalization data. This enables local health agencies to evaluate candidate interventions while explicitly accounting for uncertainty. Applied to COVID-19 in Michigan counties, our method recovers core parameters (transmissibility, latent period, asymptomatic transmissibility, underreporting, hospitalization risk, and duration) that align with empirical estimates, while demonstrating regional variation linked to age and comorbidity patterns. We find that intervention effectiveness cannot be reliably predicted from simple demographic predictors such as age structure, population density, or workforce participation. While school closures aligned with child population in some settings, other interventions showed weak or counterintuitive relationships with demographics. Traditional ODE models with random mixing assumptions cannot capture how interventions target specific contact networks, making it impossible to assess whether demographic proxies predict intervention success. Our framework addresses this gap by explicitly modeling intervention mechanisms within heterogeneous contact structures. Solely using routine case and hospitalization data, our method enables practical, uncertainty-aware decision support for local health agencies facing COVID-19, influenza, RSV, or future novel pathogens. 1 Significance Statement: During emerging outbreaks, policymakers must act before data are complete. We introduce a computational framework that bridges the gap between sparse local data and agent-based models, enabling evaluation of interventions under significant uncertainty. Our method captures how specific contact networks drive local transmission by moving beyond the random-mixing assumptions of compartmental models. We apply our framework to COVID-19 in diverse Michigan counties. Our method identifies which intervention policies are robust to the inherent uncertainty in early outbreaks for each specific community. This disease-agnostic approach empowers local agencies to make evidence-based decisions tailored to their unique population structures and contact patterns.